Browse All
Displaying 936 - 940 of 2280
Author:Green, Ilana Navis, Allison Dunleavy, Katie Klein, Oscar Cohen, Alan
Session Name:P13: Infectious Disease: HIV and PML
Topic:Infectious Disease
Program Number:P13.002
Author Institution:Icahn School of Medicine at Mount Sinai, New York, NY
Author:Ontaneda, Daniel McGinley, Marisa Harvey, Tucker Fitzgerald, Kathryn Mowry, Ellen Cohen, Jeffrey Briggs, Farren
Session Name:S31: MS Clinical Decision Making and Special Populations
Topic:MS and Inflammatory Disease
Program Number:S31.003
Author Institution:Cleveland Clinic, Cleveland, OH Johns Hopkins University, Baltimore, MD Case Western Reserve University, Cleveland, OH
Author:Alvarez, Enrique Hersh, Carrie Robertson, Derrick Das Gupta, Ayan Hu, Xixi Zielman, Ronald Boer, Ibolya Cheadle, Andy Cohen, Jeffrey
Session Name:P8: MS Therapeutics 2
Program Number:P8.002
Author Institution:Department of Neurology, Rocky Mountain Multiple Sclerosis Center at the University of Colorado , Aurora, CO Lou Ruvo Center for Brain Health, Cleveland Clinic Mellen Program for MS, Las Vegas, NV Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL Novartis Healthcare, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ Novartis Pharma B.V., Amsterdam, Netherlands Novartis Pharma AG, Basel, Switzerland Department of Neurology, Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH
Author:Cohen, Jeffrey Hauser, Stephen Cross, Anne Winthrop, Kevin Wiendl, Heinz Nicholas, Jacqueline Meuth, Sven Giacomini, Paul Sacca, Francesco Zielman, Ronald Das Gupta, Ayan Hu, Xixi Sullivan, Roseanne DeLasHeras, Virginia Kappos, Ludwig
Program Number:P8.004
Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA Washington University School of Medicine, Saint Louis, MO, USA, Clayton, MO Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, USA, Portland, OR University of Muenster, Muenster, Germany, Muenster, Germany OhioHealth Multiple Sclerosis Center, Columbus, OH, USA, Columbus, OH Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy, Napoli, Italy Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Nakamura, Kunio Husak, Scott Bermel, Robert Cohen, Jeffrey Ontaneda, Daniel
Session Name:P10: MS Neuroimaging 1
Program Number:P10.011
Author Institution:Cleveland Clinic, Cleveland, OH
